CAITLIN LOCKHART: Open Payments
NPI 1497428783 · ENGLEWOOD, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,043 in 57 payments from 21 companies in 2025. Trend: 2023 $235 · 2024 $1,064 · 2025 $1,043
Food & beverage: $1,043
| Company | Payments | Amount |
|---|---|---|
| Amneal Pharmaceuticals LLC | 7 | $171 |
| Novo Nordisk Inc | 15 | $150 |
| Amphastar Pharmaceuticals, Inc. | 2 | $64 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $61 |
| Radius Health, Inc. | 3 | $60 |
| Amgen Inc. | 3 | $57 |
| Alexion Pharmaceuticals, Inc. | 2 | $55 |
| Lilly USA, LLC | 3 | $52 |
| Chiesi USA, Inc. | 2 | $50 |
| Antares Pharma, Inc. | 2 | $45 |
Products named: UNITHROID, BAQSIMI, JARDIANCE, Tymlos, STRENSIQ, MOUNJARO, MYCAPSSA, XYOSTED.
Industry payments across CO — which companies pay providers there.
